Agios Pharmaceuticals, Inc

(NASDAQ:AGIO)

Latest On Agios Pharmaceuticals, Inc (AGIO):

Date/Time Type Description Signal Details
2023-05-24 13:19 ESTNewsAgios Pharmaceuticals: Good Execution, A Good Deal Of Cash, Some HurdlesN/A
2023-05-04 22:01 ESTNewsAgios Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-04 22:01 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 09:00 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.47 beats by $0.23, revenue of $5.6M beats by $0.37MN/A
2023-05-03 20:46 ESTNewsAgios Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-02-24 01:00 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q4 2022 Earnings Call TranscriptN/A
2023-02-23 11:31 ESTNewsAgios Pharmaceuticals GAAP EPS of -$4.23 beats by $2.06, revenue of $14.24M beats by $0.35MN/A
2023-02-22 09:46 ESTNewsAgios Pharma: Multiple Growth Catalysts If Pyrukynd Conversions Pull ThroughN/A
2023-01-11 19:46 ESTNewsAgios Pharmaceuticals (AGIO) presents at 41st Annual J.P. Morgan Healthcare Conference - SlideshowN/A
2022-12-12 09:07 ESTNewsAgios rare blood disorder drug Pyrukynd sustains benefits in patients in long term dataN/A
2022-11-17 17:06 ESTNewsAgios Pharmaceuticals upgraded to neutral at Goldman Sachs on Pyrukynd outlookN/A
2022-11-12 00:39 ESTNewsAgios granted EU approval for Pyrukynd in pyruvate kinase deficiencyN/A
2022-11-04 15:26 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 15:26 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-03 22:53 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.49 beats by $0.27, revenue of $3.52M misses by $1.72MN/A
2022-10-30 23:18 ESTNewsAgios Pharmaceuticals: A Big Year On The HorizonN/A
2022-10-27 21:23 ESTNewsAgios sells its rights to royalties on U.S. sales of cancer drug Tibsovo for $131.8MN/A
2022-09-19 18:38 ESTNewsAgios appoints Cecilia Jones as finance chiefN/A
2022-09-16 22:56 ESTNewsAgios Pyrukynd for rare blood disorder gets EMA panel backing for approval in EUN/A
2022-09-07 13:53 ESTNewsAgios CFO Jonathan Biller to quitN/A
2022-09-01 18:52 ESTNewsAgios adds more than 13% after Novo deal to acquire rival FormaN/A
2022-08-07 19:20 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-07 19:20 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-04 23:04 ESTNewsAgios stock rises as Q2 sees new drug Pyrukynd bring in revenueN/A
2022-08-04 07:32 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.68 beats by $0.07N/A
2022-07-27 15:35 ESTNewsAgios gains as blood disorder therapy draws positive viewsN/A
2022-07-26 12:48 ESTNewsAgios Pharmaceuticals Is A Buy On Coming Revenue RampN/A
2022-07-12 22:36 ESTNewsAgios Pharmaceuticals hires new CEON/A
2022-07-12 22:36 ESTNewsAgios Pharmaceuticals appoints new board chair, CEON/A
2022-06-18 02:50 ESTNewsAgios Pharmaceuticals (AGIO) Presents At EHA 2022 Conference - SlideshowN/A
2022-05-18 02:34 ESTNewsAgios chief scientific officer to depart amid layoffs as company pivots to genetic diseasesN/A
2022-05-10 23:23 ESTNewsAgios: Approved Product, Upcoming CatalystsN/A
2022-05-10 01:38 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-05 20:57 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.74 beats by $0.07, revenue of $0.83M misses by $1.88MN/A
2022-05-05 20:57 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 22:11 ESTNewsAgios Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-02-25 04:07 ESTNewsAgios Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-25 04:06 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 08:21 ESTNewsAgios Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-24 08:20 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.81 misses by $0.12N/A
2022-02-23 12:21 ESTNewsAgios Pharmaceuticals With FDA Approval Is A BuyN/A
2022-02-19 06:37 ESTNewsAgios Pharmaceuticals' mitapivat approved by FDA for pyruvate kinase deficiencyN/A
2022-02-19 06:36 ESTNewsAgios vindicated with FDA approval for Pyrukynd - H.C. WainwrightN/A
2022-02-18 08:40 ESTNewsAgios Pyrukynd for rare blood disorder gets US FDA approvalN/A
2022-01-20 15:39 ESTNewsAgios Before The February PDUFAN/A
2021-12-14 09:40 ESTNewsAgios presents mitapivat long-term data in PK deficiency at ASH 2021N/A
2021-11-04 03:28 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Dr. Jackie Fouse on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-04 03:28 ESTNewsAgios Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-03 07:29 ESTNewsAgios Pharmaceuticals EPS beats by $1.46N/A
2021-11-02 11:38 ESTNewsAgios Pharmaceuticals Q3 2021 Earnings PreviewN/A

About Agios Pharmaceuticals, Inc (AGIO):

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers TIBSOVO (ivosidenib), an oral targeted inhibitor for treating adult patients with relapsed or refractory acute myeloid leukemia (R/R AML), as well as to treat patients with newly diagnosed AML; and IDHIFA (enasidenib), an oral targeted inhibitor for patients with R/R AML and an isocitrate dehydrogenase 2 mutation. It is also developing TIBSOVO, which has completed Phase II clinical trials to treat IC eligible frontline AML; that is in Phase III clinical trials for treating IC ineligible frontline AML; and that is in Phase III clinical trials for the treatment of cholangiocarcinoma, as well as in early stage clinical development to treat glioma and solid tumors. In addition, the company is developing IDHIFA, which has completed Phase II clinical study for treating IC eligible frontline AML; and that is in Phase I/II clinical trials for the treatment of IC ineligible frontline AML. Further, it is developing mitapivat, which is in Phase III clinical trials to treat pyruvate kinase deficiency, as well as in Phase II clinical study for treating thalassemia and sickle cell disease; vorasidenib (AG-881) that is in Phase I clinical trials for the treatment of solid tumors, including glioma; AG-270, which is in Phase I dose-escalation trial to treat methylthioadenosine phosphorylase deleted tumors; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is based in Cambridge, Massachusetts.

AGIO Quotes by TradingView

See Advanced Chart

General

  • Name Agios Pharmaceuticals, Inc
  • Symbol AGIO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 562
  • Fiscal Year EndDecember
  • IPO Date2013-07-24
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.agios.com
View More

Valuation

  • Forward PE 8.1
  • Price/Sales (Trailing 12 Mt.) 17.51
  • Price/Book (Most Recent Quarter) 8.98
  • Enterprise Value Revenue 15.36
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$6.07
  • Next Year EPS Estimate -$6.10
  • Next Quarter EPS Estimate -$1.29
  • Profit Margin -161%
  • Operating Margin -156%
  • Return on Assets -23%
  • Return on Equity -63%
  • Revenue 203.2 million
  • Earnings Per Share -$6.67
  • Revenue Per Share $2.95
  • Gross Profit -167079000
  • Quarterly Earnings Growth 24.3%
View More

Highlights

  • Market Capitalization 3.38 billion
  • EBITDA -399112000
  • PE Ratio 1.63
  • Analyst Target Price $64.89
  • Book Value Per Share $5.77
View More

Share Statistics

  • Shares Outstanding 69.36 million
  • Shares Float 61.75 million
  • % Held by Insiders 1133%
  • % Held by Institutions 92.34%
  • Shares Short 5.82 million
  • Shares Short Prior Month 5.68 million
  • Short Ratio 8.4
  • Short % of Float 11%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 1.62
  • 52 Week High $58.93
  • 52 Week Low $32.47
  • 50 Day Moving Average 50.87
  • 200 Day Moving Average 42.95
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Agios Pharmaceuticals, Inc (AGIO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Agios Pharmaceuticals, Inc (AGIO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$44.05 million-$1.41-$1.31-7.96%
2020-09-302020-11-05$34.71 million-$1.43-$1.36-5.47%
2020-06-302020-07-30$N/A-$1.31-$1.363.72%
2020-03-312020-04-30$N/A-$0.59-$1.6463.94%
2019-12-312020-02-13$35.44 million-$1.60-$1.684.94%
2019-09-302019-10-31$26.02 million-$1.81-$1.81-0.22%
2019-06-302019-08-01$26.22 million-$1.87-$1.70-9.89%
2019-03-312019-05-02$30.23 million-$1.59-$1.759.24%
2018-12-312019-02-14$30.01 million-$1.58-$1.664.62%
2018-09-302018-11-01$15.2 million-$1.63-$1.62-0.73%
2018-06-302018-08-02$40.41 million-$1.19-$1.5523.07%
2018-03-312018-05-04$8.76 million-$1.63-$1.651.41%
2017-12-312018-02-14$9.8 million-$1.81-$1.61-12.63%
2017-09-302017-11-01$11.36 million-$1.59-$1.7810.46%
2017-06-302017-08-08$11.35 million-$1.78-$1.57-13.53%
2017-03-312017-05-04$10.51 million-$1.56-$1.8013.19%
2016-12-312017-02-16$22.65 million-$1.34-$1.5111.38%
2016-09-302016-11-03$8.99 million-$1.63-$1.51-8.2%
2016-06-302016-08-04$6.98 million-$1.47-$1.30-12.77%
2016-03-312016-05-05$31.28 million-$0.61-$0.9334.47%
2015-12-312016-02-18$6.22 million-$1.08-$0.53-102.21%
2015-09-302015-11-05$5.48 million-$1.07-$0.88-21.59%
2015-06-302015-08-06$13.22 million-$0.85-$0.46-84.78%
2015-03-312015-05-07$34.2 million-$0.13-$0.9285.87%
2014-12-312015-02-17$14.64 million-$0.76-$0.58-31.03%
2014-09-302014-11-07$33.9 million$0.10-$0.52119.23%
2014-06-302014-08-07$8.41 million-$0.54-$0.40-35%
2014-03-312014-05-08$8.41 million-$0.39-$0.37-5.41%
2013-12-312014-03-06$6.74 million-$0.40-$0.34-17.65%
2013-09-302013-11-07$6.27 million-$0.47-$0.29-62.07%
2013-06-302013-09-05$6.27 million-$2.80-$0.32-775%

Agios Pharmaceuticals, Inc (AGIO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Agios Pharmaceuticals, Inc (AGIO) Chart:

Agios Pharmaceuticals, Inc (AGIO) News:

Below you will find a list of latest news for Agios Pharmaceuticals, Inc (AGIO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Agios Pharmaceuticals, Inc (AGIO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-12-1912.50CALL0 0206.14TRUE00
2025-12-19159CALL0 1146.34TRUE00
2025-12-1917.56CALL0 4127.86TRUE00
2025-12-19205.4CALL7 1896.89TRUE1.030.24
2025-12-1922.54CALL11 35106.49TRUE1.250.45
2025-12-19252.5CALL758 218096.35FALSE0.80.47
2025-12-19301CALL37 58596.15FALSE0.250.33
2025-12-19350.55CALL751 1034108.18FALSE0.150.38
2025-12-19400.29CALL10 3245114.23FALSE-0.06-0.17
2025-12-19450.24CALL18 789128.69FALSE0.040.2
2025-12-19500.15CALL3 1892133.29FALSE-0.05-0.25
2025-12-19550.14CALL0 631184.99FALSE00
2025-12-19607.5CALL0 418194.48FALSE00
2025-12-19650.25CALL0 64206.78FALSE00
2025-12-19705CALL0 146217.93FALSE00
2025-12-19750.1CALL0 42211.78FALSE00
2025-12-19800.13CALL0 21226.83FALSE00
2025-12-19850CALL0 0246.21FALSE00
2025-12-19902.25CALL0 189201.43FALSE00
2025-12-1912.50.2PUT6 0155.89FALSE0.20
2025-12-19150.12PUT1 44107.07FALSE-0.18-0.6
2025-12-1917.50.4PUT129 936107.23FALSE-0.22-0.35
2025-12-19200.85PUT114 363101.18FALSE-0.53-0.38
2025-12-1922.51.6PUT10329 25095.85FALSE-0.9-0.36
2025-12-19252.82PUT97 25794.93TRUE-1.29-0.31
2025-12-19306.35PUT13 169996TRUE-0.55-0.08
2025-12-193512.98PUT0 120798.39TRUE00
2025-12-194017.25PUT0 553140.72TRUE00
2025-12-194521.9PUT0 150TRUE00
2025-12-195011.9PUT0 00TRUE00
2025-12-19550PUT0 00TRUE00
2025-12-19600PUT0 00TRUE00
2025-12-19650PUT0 00TRUE00
2025-12-19700PUT0 00TRUE00
2025-12-19750PUT0 00TRUE00
2025-12-19800PUT0 00TRUE00
2025-12-19850PUT0 00TRUE00
2025-12-19900PUT0 00TRUE00
2026-01-1612.50CALL0 0148.34TRUE00
2026-01-161510.1CALL20 0105.04TRUE10.10
2026-01-1617.50CALL0 0109.81TRUE00
2026-01-16205.8CALL4 2082.29TRUE1.30.29
2026-01-1622.54.19CALL7 5680.24TRUE1.190.4
2026-01-16253CALL67 38480.82FALSE0.70.3
2026-01-16301.61CALL28 11085.76FALSE0.410.34
2026-01-16350.75CALL0 30380.8FALSE00
2026-01-16400.5CALL4 142692.65FALSE-0.1-0.17
2026-01-16450.2CALL66 110988.2FALSE-0.3-0.6
2026-01-16500.38CALL2 934113.25FALSE-0.07-0.16
2026-01-16550.35CALL2 558122FALSE0.350
2026-01-16600.13CALL141 190110.69FALSE-0.37-0.74
2026-01-16650.3CALL0 247153.4FALSE00
2026-01-1612.50PUT0 0144.35FALSE00
2026-01-16150PUT0 0124.59FALSE00
2026-01-1617.50PUT0 083.98FALSE00
2026-01-16201.15PUT1 4983.79FALSE-0.45-0.28
2026-01-1622.52.05PUT226 1103382.07FALSE-0.92-0.31
2026-01-16253.5PUT18 22886.4TRUE-0.77-0.18
2026-01-16308.77PUT0 274184.86TRUE00
2026-01-163510.8PUT10252 1132875.47TRUE-1.4-0.11
2026-01-164015.46PUT1 41869.48TRUE15.460
2026-01-164516.6PUT0 190TRUE00
2026-01-165016.6PUT0 60TRUE00
2026-01-165520.5PUT0 00TRUE00
2026-01-16600PUT0 00TRUE00
2026-01-16650PUT0 00TRUE00
2026-02-2012.50CALL0 0114.57TRUE00
2026-02-20150CALL0 0112.78TRUE00
2026-02-2017.58CALL0 27101.33TRUE00
2026-02-20206CALL0 383.88TRUE00
2026-02-2022.55CALL5 5280.38TRUE1.150.3
2026-02-20253.8CALL24 3179.29FALSE0.70.23
2026-02-20302.75CALL15 11291.11FALSE0.90.49
2026-02-20351.8CALL4 9785.32FALSE0.20.13
2026-02-20400.9CALL12179 1229386FALSE-0.1-0.1
2026-02-20450.55CALL20 9986.38FALSE-0.19-0.26
2026-02-20500.42CALL4 4490.78FALSE-0.08-0.16
2026-02-205512.14CALL0 55115.42FALSE00
2026-02-20600.27CALL0 218119.74FALSE00
2026-02-20650CALL0 0129.03FALSE00
2026-02-2012.50PUT0 0125.54FALSE00
2026-02-20150PUT0 087.8FALSE00
2026-02-2017.51.4PUT0 13384.48FALSE00
2026-02-20201.75PUT16 582.83FALSE-0.95-0.35
2026-02-2022.52.6PUT25 177.67FALSE2.60
2026-02-20253.81PUT56 10175.28TRUE-1.29-0.25
2026-02-20307.3PUT22 5177.94TRUE-2.05-0.22
2026-02-203513PUT0 5681.87TRUE00
2026-02-204011.59PUT0 5382.36TRUE00
2026-02-204522.3PUT0 14499.07TRUE00
2026-02-205016.9PUT0 114102.97TRUE00
2026-02-205520.6PUT0 00TRUE00
2026-02-206024.2PUT0 10TRUE00
2026-02-20650PUT0 00TRUE00
2026-05-1512.513.2CALL14 097.37TRUE13.20
2026-05-15150CALL0 092.98TRUE00
2026-05-1517.58CALL0 292.11TRUE00
2026-05-15207.2CALL0 1281.17TRUE00
2026-05-1522.56CALL0 879.31TRUE00
2026-05-15255CALL13 9674.03FALSE0.70.16
2026-05-15303.7CALL5 45478.87FALSE0.20.06
2026-05-15352CALL1 32569.64FALSE-0.17-0.08
2026-05-15402.1CALL4 5583.79FALSE0.250.14
2026-05-15451.4CALL21 2681.23FALSE00
2026-05-15501.25CALL6 4486.41FALSE0.050.04
2026-05-15559.2CALL0 485.38FALSE00
2026-05-15600.8CALL0 1990.11FALSE00
2026-05-15650.61CALL0 588.93FALSE00
2026-05-1512.50PUT0 085.48FALSE00
2026-05-15150PUT0 074.57FALSE00
2026-05-1517.50PUT0 080.84FALSE00
2026-05-15202.45PUT3 2974.24FALSE-0.81-0.25
2026-05-1522.53.6PUT1 6873.79FALSE-0.8-0.18
2026-05-15254.9PUT2 7372.44TRUE-1.37-0.22
2026-05-15308.1PUT4 2370.69TRUE-2-0.2
2026-05-153514.01PUT0 34078.17TRUE00
2026-05-154018.22PUT0 4779.72TRUE00
2026-05-154514.3PUT0 471.06TRUE00
2026-05-155017.3PUT0 178.27TRUE00
2026-05-155523PUT0 620TRUE00
2026-05-15600PUT0 00TRUE00
2026-05-15650PUT0 00TRUE00
2026-12-1812.50CALL0 084.05TRUE00
2026-12-18150CALL0 082.57TRUE00
2026-12-1817.50CALL0 080.39TRUE00
2026-12-18208.2CALL0 472.3TRUE00
2026-12-1822.57.3CALL0 770.92TRUE00
2026-12-18256CALL0 2770.37FALSE00
2026-12-18305.9CALL11290 372.84FALSE1.450.33
2026-12-18354.8CALL2 273.56FALSE0.60.14
2026-12-18400CALL0 071.13FALSE00
2026-12-18450CALL0 072.18FALSE00
2026-12-18501.95CALL0 271.65FALSE00
2026-12-18550CALL0 064.71FALSE00
2026-12-18600CALL0 067.24FALSE00
2026-12-18651.33CALL0 167.21FALSE00
2026-12-1812.50PUT0 070.27FALSE00
2026-12-18150PUT0 065.07FALSE00
2026-12-1817.50PUT0 074.08FALSE00
2026-12-18203.71PUT0 671.55FALSE00
2026-12-1822.55.02PUT0 272.21FALSE00
2026-12-18256.68PUT4 469.43TRUE0.130.02
2026-12-18300PUT0 068.84TRUE00
2026-12-183513.6PUT2 068.01TRUE13.60
2026-12-18400PUT0 068.07TRUE00
2026-12-18450PUT0 069.49TRUE00
2026-12-18500PUT0 069.49TRUE00
2026-12-18550PUT0 074.09TRUE00
2026-12-18600PUT0 067.34TRUE00
2026-12-18650PUT0 00TRUE00
2027-01-1512.514.45CALL15 1585.94TRUE1.450.11
2027-01-15150CALL0 080.21TRUE00
2027-01-1517.50CALL0 077.33TRUE00
2027-01-15208.44CALL0 265.27TRUE00
2027-01-1522.56.5CALL0 468.79TRUE00
2027-01-15257.49CALL13 2270.73FALSE1.640.28
2027-01-15305.89CALL1 170.06FALSE1.390.31
2027-01-15353.6CALL0 4069.93FALSE00
2027-01-15403CALL4 3962.12FALSE-0.04-0.01
2027-01-15452.5CALL0 2270.59FALSE00
2027-01-15500CALL0 069.62FALSE00
2027-01-15550CALL0 063.03FALSE00
2027-01-15601.85CALL0 161.59FALSE00
2027-01-15651.42CALL0 763.64FALSE00
2027-01-1512.50PUT0 066.91FALSE00
2027-01-15150PUT0 059.46FALSE00
2027-01-1517.50PUT0 071.83FALSE00
2027-01-15203.79PUT0 670.02FALSE00
2027-01-1522.55.5PUT0 25067.34FALSE00
2027-01-15256.6PUT818 1166.61TRUE-0.38-0.05
2027-01-15309.9PUT10 066.44TRUE9.90
2027-01-153511.3PUT0 169.58TRUE00
2027-01-15400PUT0 067.87TRUE00
2027-01-15450PUT0 068.89TRUE00
2027-01-15500PUT0 066.54TRUE00
2027-01-15550PUT0 058.7TRUE00
2027-01-15600PUT0 066.99TRUE00
2027-01-15650PUT0 00TRUE00
2028-01-2112.50CALL0 063.96TRUE00
2028-01-211513.3CALL0 1266TRUE00
2028-01-2117.50CALL0 064.16TRUE00
2028-01-21200CALL0 059.61TRUE00
2028-01-2122.50CALL0 060.77TRUE00
2028-01-21258.8CALL6 959.31FALSE-0.6-0.06
2028-01-21306CALL0 159.81FALSE00
2028-01-21355.8CALL0 158.54FALSE00
2028-01-21404.6CALL0 1360.9FALSE00
2028-01-21450CALL0 056.09FALSE00
2028-01-21503.1CALL0 059.1FALSE00
2028-01-21550CALL0 057.15FALSE00
2028-01-21600CALL0 056.9FALSE00
2028-01-21650CALL0 058.97FALSE00
2028-01-2112.50PUT0 060.02FALSE00
2028-01-21150PUT0 059.33FALSE00
2028-01-2117.50PUT0 056.5FALSE00
2028-01-21205PUT0 156.31FALSE00
2028-01-2122.50PUT0 059.26FALSE00
2028-01-21258.5PUT0 158.1TRUE00
2028-01-21300PUT0 057.74TRUE00
2028-01-21350PUT0 056.65TRUE00
2028-01-21400PUT0 057.18TRUE00
2028-01-21450PUT0 058.2TRUE00
2028-01-21500PUT0 057.02TRUE00
2028-01-21550PUT0 060.4TRUE00
2028-01-21600PUT0 059.48TRUE00
2028-01-21650PUT0 060.79TRUE00

Latest AGIO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST11$17.4
Jun 13, 2022 7:59 PM EST189$17.4
Jun 13, 2022 7:59 PM EST128$17.4
Jun 13, 2022 7:59 PM EST200$17.38
Jun 13, 2022 7:59 PM EST17$17.4

Agios Pharmaceuticals, Inc (AGIO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520167148/0001193125-20-167148-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000021545719003331/0000215457-19-003331-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506619000835/0000315066-19-000835-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506620000791/0000315066-20-000791-index.htm
2020-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506620001684/0000315066-20-001684-index.htm
2019-10-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000083423719000203/0000834237-19-000203-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000083423720008047/0000834237-20-008047-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000090221919000091/0000902219-19-000091-index.htm
2020-01-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000090221920000008/0000902219-20-000008-index.htm
2019-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000093247119002231/0000932471-19-002231-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000093247119004832/0000932471-19-004832-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000110465919064171/0001104659-19-064171-index.htm
2019-11-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1439222/000110465919064173/0001104659-19-064173-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000110465920017624/0001104659-20-017624-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000110465920018297/0001104659-20-018297-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518314801/0001193125-18-314801-index.htm
2018-11-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518328948/0001193125-18-328948-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518341083/0001193125-18-341083-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518353307/0001193125-18-353307-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519003167/0001193125-19-003167-index.htm
2019-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519018824/0001193125-19-018824-index.htm
2019-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519039198/0001193125-19-039198-index.htm
2019-02-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519039513/0001193125-19-039513-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519051918/0001193125-19-051918-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519107805/0001193125-19-107805-index.htm
2019-04-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519110870/0001193125-19-110870-index.htm
2019-04-18DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1439222/000119312519110887/0001193125-19-110887-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519133821/0001193125-19-133821-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519134882/0001193125-19-134882-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519148009/0001193125-19-148009-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519162771/0001193125-19-162771-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519164072/0001193125-19-164072-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519166109/0001193125-19-166109-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519209747/0001193125-19-209747-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519237824/0001193125-19-237824-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519258364/0001193125-19-258364-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519275491/0001193125-19-275491-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519279631/0001193125-19-279631-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519283514/0001193125-19-283514-index.htm
2019-11-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1439222/000119312519285887/0001193125-19-285887-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519288482/0001193125-19-288482-index.htm
2019-11-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1439222/000119312519288495/0001193125-19-288495-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519298670/0001193125-19-298670-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519309199/0001193125-19-309199-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520005857/0001193125-20-005857-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520006338/0001193125-20-006338-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520034263/0001193125-20-034263-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520037796/0001193125-20-037796-index.htm
2020-02-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520041964/0001193125-20-041964-index.htm
2020-04-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520109284/0001193125-20-109284-index.htm
2020-04-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1439222/000119312520109288/0001193125-20-109288-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520127627/0001193125-20-127627-index.htm
2020-04-30POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1439222/000119312520128793/0001193125-20-128793-index.htm
2020-04-30S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1439222/000119312520128809/0001193125-20-128809-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520155665/0001193125-20-155665-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520155682/0001193125-20-155682-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520167148/0001193125-20-167148-index.htm
2020-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520203351/0001193125-20-203351-index.htm
2020-09-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520240994/0001193125-20-240994-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520249634/0001193125-20-249634-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520286235/0001193125-20-286235-index.htm
2018-09-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2018-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050631/0001209191-18-050631-index.htm
2018-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2018-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-064/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118057372/0001209191-18-057372-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118059146/0001209191-18-059146-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118064102/0001209191-18-064102-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004950/0001209191-19-004950-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004955/0001209191-19-004955-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004961/0001209191-19-004961-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119007343/0001209191-19-007343-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011486/0001209191-19-011486-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011489/0001209191-19-011489-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011491/0001209191-19-011491-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011494/0001209191-19-011494-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011498/0001209191-19-011498-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119012942/0001209191-19-012942-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013509/0001209191-19-013509-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013515/0001209191-19-013515-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013525/0001209191-19-013525-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013531/0001209191-19-013531-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013536/0001209191-19-013536-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119025785/0001209191-19-025785-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033614/0001209191-19-033614-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033616/0001209191-19-033616-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033618/0001209191-19-033618-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033620/0001209191-19-033620-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033622/0001209191-19-033622-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033625/0001209191-19-033625-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033626/0001209191-19-033626-index.htm
2018-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922218000018/0001439222-18-000018-index.htm
2019-02-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000004/0001439222-19-000004-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000009/0001439222-19-000009-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000011/0001439222-19-000011-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000017/0001439222-19-000017-index.htm
2019-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000021/0001439222-19-000021-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000023/0001439222-19-000023-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000025/0001439222-19-000025-index.htm
2019-12-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000027/0001439222-19-000027-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000028/0001439222-19-000028-index.htm
2019-12-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000030/0001439222-19-000030-index.htm
2020-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000002/0001439222-20-000002-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000003/0001439222-20-000003-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2020-02-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000014/0001439222-20-000014-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000015/0001439222-20-000015-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000016/0001439222-20-000016-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000017/0001439222-20-000017-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000018/0001439222-20-000018-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000020/0001439222-20-000020-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000021/0001439222-20-000021-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000022/0001439222-20-000022-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000023/0001439222-20-000023-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000024/0001439222-20-000024-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000025/0001439222-20-000025-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000026/0001439222-20-000026-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000027/0001439222-20-000027-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000028/0001439222-20-000028-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000029/0001439222-20-000029-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000030/0001439222-20-000030-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000031/0001439222-20-000031-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000032/0001439222-20-000032-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000033/0001439222-20-000033-index.htm
2020-04-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000039/0001439222-20-000039-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000049/0001439222-20-000049-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000050/0001439222-20-000050-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000051/0001439222-20-000051-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000052/0001439222-20-000052-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000053/0001439222-20-000053-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000054/0001439222-20-000054-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000055/0001439222-20-000055-index.htm
2020-07-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000059/0001439222-20-000059-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000061/0001439222-20-000061-index.htm
2020-10-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000063/0001439222-20-000063-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000069/0001439222-20-000069-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000156223019000005/0001562230-19-000005-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000156223020000005/0001562230-20-000005-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000162828019007955/0001628280-19-007955-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719003422/9999999997-19-003422-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719003444/9999999997-19-003444-index.htm
2019-07-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719006154/9999999997-19-006154-index.htm

Agios Pharmaceuticals, Inc (AGIO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agios Pharmaceuticals, Inc (AGIO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1133%
Institutional Ownership: 9234%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-09-28Carman AlensonPrincipal Accounting OfficerSell152.0076.4511,620.400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2020-02-16David P SchenkeinDirectorBuy8,125.00105,692.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000015/0001439222-20-000015-index.htm
2020-02-22David P SchenkeinDirectorBuy2,775.00105,933.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000022/0001439222-20-000022-index.htm
2020-04-13Christopher BowdenChief Medical OfficerBuy5,280.0010,598.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000028/0001439222-20-000028-index.htm
2019-03-01Steven L. HoerterChief Commercial OfficerSell5,000.0066.01330,050.0010,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-04Steven L. HoerterChief Commercial OfficerSell5,000.0068.00340,000.0010,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell5,854.0066.03386,539.6211,384.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2020-05-20Christopher BowdenChief Medical OfficerBuy3,583.0035.16125,978.2811,889.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2019-02-16Steven L. HoerterChief Commercial OfficerBuy2,750.0011,981.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011494/0001209191-19-011494-index.htm
2019-02-16Andrew HirschChief Financial OfficerBuy2,750.0013,195.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011491/0001209191-19-011491-index.htm
2019-05-31IAN T CLARKDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033616/0001209191-19-033616-index.htm
2019-05-31JACQUALYN A FOUSEChief Executive OfficerBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033620/0001209191-19-033620-index.htm
2019-05-31Maykin HoDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033622/0001209191-19-033622-index.htm
2019-05-31Paul J ClancyDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033614/0001209191-19-033614-index.htm
2019-01-20Andrew HirschChief Financial OfficerBuy15,000.0015,000.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004961/0001209191-19-004961-index.htm
2019-01-20Steven L. HoerterChief Commercial OfficerBuy15,000.0015,000.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004955/0001209191-19-004955-index.htm
2020-02-16Andrew HirschChief Financial OfficerBuy2,750.0015,127.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000016/0001439222-20-000016-index.htm
2020-02-04Christopher BowdenChief Medical OfficerBuy8,526.0035.16299,774.1615,841.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2019-03-01Steven L. HoerterChief Commercial OfficerBuy5,000.0039.76198,800.0015,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-04Steven L. HoerterChief Commercial OfficerBuy5,000.0039.76198,800.0015,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2020-02-04Christopher BowdenChief Medical OfficerSell14,191.0050.03709,962.961,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-04Christopher BowdenChief Medical OfficerSell35,447.0050.101,776,025.851,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-11Christopher BowdenChief Medical OfficerSell621.0050.0231,063.231,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2020-02-13Christopher BowdenChief Medical OfficerSell7,100.0050.16356,111.861,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2019-03-15Christopher BowdenChief Medical OfficerBuy10,000.0035.16351,600.0017,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-01Christopher BowdenChief Medical OfficerBuy10,000.0035.16351,600.0017,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2020-02-22Andrew HirschChief Financial OfficerBuy3,333.0017,574.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000024/0001439222-20-000024-index.htm
2019-11-12CORP /DE/ CELGENE10% Share HolderBuy403,225.0031.0012,499,975.001,777,824.00https://www.sec.gov/Archives/edgar/data/1439222/000110465919064171/0001104659-19-064171-index.htm
2019-12-26Carman AlensonPrincipal Accounting OfficerSell2,950.0050.09147,765.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000030/0001439222-19-000030-index.htm
2020-02-20Carman AlensonPrincipal Accounting OfficerSell2,427.0053.37129,528.99184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000020/0001439222-20-000020-index.htm
2020-02-26Carman AlensonPrincipal Accounting OfficerSell472.0047.1222,240.64184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000025/0001439222-20-000025-index.htm
2020-03-02Carman AlensonPrincipal Accounting OfficerSell345.0047.3016,318.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000027/0001439222-20-000027-index.htm
2020-09-02Carman AlensonPrincipal Accounting OfficerSell250.0039.939,982.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000061/0001439222-20-000061-index.htm
2019-05-31David ScaddenDirectorBuy1,400.001,971.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033626/0001209191-19-033626-index.htm
2020-04-13Andrew HirschChief Financial OfficerBuy5,387.0021,905.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000031/0001439222-20-000031-index.htm
2018-09-12JOHN MARAGANOREDirectorSell14,162.0071.741,015,981.8822,047.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2020-02-11Christopher BowdenChief Medical OfficerBuy621.0035.1621,834.362,271.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2018-12-21Scott BillerChief Scientific OfficerBuy20,500.002.3447,918.7524,637.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118064102/0001209191-18-064102-index.htm
2020-04-22Andrew HirschChief Financial OfficerBuy5,893.0026,199.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000033/0001439222-20-000033-index.htm
2019-02-27Scott BillerChief Scientific OfficerSell9,000.0065.00585,000.0026,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell200.0068.2213,644.0026,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerSell599.0068.1240,803.8826,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell2,600.0067.73176,098.0026,711.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-05Scott BillerChief Scientific OfficerBuy428.0031.6413,541.9226,939.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerSell2,401.0067.61162,331.6127,110.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-02-16Scott BillerChief Scientific OfficerBuy2,750.0027,387.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011486/0001209191-19-011486-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy1,766.000.47830.0228,277.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell200.0066.4513,290.0029,311.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-05Scott BillerChief Scientific OfficerBuy2,572.0039.76102,262.7229,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerBuy3,000.0039.76119,280.0029,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2020-05-29JOHN MARAGANOREDirectorBuy1,878.0030,172.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000050/0001439222-20-000050-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy4,154.009.0537,593.7032,431.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2020-05-29IAN T CLARKDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000051/0001439222-20-000051-index.htm
2020-05-29Maykin HoDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000049/0001439222-20-000049-index.htm
2020-05-29Paul J ClancyDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000053/0001439222-20-000053-index.htm
2019-06-11Scott BillerChief Scientific OfficerBuy7,218.002.3416,872.0833,729.00https://www.sec.gov/Archives/edgar/data/1439222/000162828019007955/0001628280-19-007955-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy3,080.0031.6497,451.2035,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-05-31Kaye I Foster-CheekDirectorBuy1,400.003,600.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033618/0001209191-19-033618-index.htm
2018-09-11JOHN MARAGANOREDirectorSell2,400.0073.82177,168.0036,209.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2020-02-05Christopher BowdenChief Medical OfficerBuy35,447.0035.161,246,316.5237,097.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2019-05-31JOHN MARAGANOREDirectorBuy1,400.0037,609.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033625/0001209191-19-033625-index.htm
2020-02-16Carman AlensonPrincipal Accounting OfficerBuy2,800.003,774.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2019-02-21Carman AlensonPrincipal Accounting OfficerBuy3,300.003,812.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119012942/0001209191-19-012942-index.htm
2020-05-29David ScaddenDirectorBuy1,878.003,849.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000054/0001439222-20-000054-index.htm
2018-09-11JOHN MARAGANOREDirectorSell11,155.0072.52808,960.6038,609.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2019-11-13JACQUALYN A FOUSEChief Executive OfficerBuy40,322.0031.001,249,982.0041,722.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000025/0001439222-19-000025-index.htm
2020-02-16Christopher BowdenChief Medical OfficerBuy2,750.004,400.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000018/0001439222-20-000018-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell21.0071.771,507.1750,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell100.0071.427,142.0050,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell1,100.0071.0578,155.0050,953.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell700.0070.2349,161.0051,032.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell2,200.0069.44152,768.0051,732.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell979.0069.4768,011.1352,053.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell900.0068.5661,704.0053,032.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-10-05Scott BillerChief Scientific OfficerBuy3,000.009.0527,150.0053,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerBuy3,000.009.0527,150.0053,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2020-04-13JACQUALYN A FOUSEChief Executive OfficerBuy12,379.0054,101.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000030/0001439222-20-000030-index.htm
2020-05-29Kaye I Foster-CheekDirectorBuy1,878.005,478.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000052/0001439222-20-000052-index.htm
2020-04-13Bruce CarChief Scientific OfficerBuy6,874.006,874.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000029/0001439222-20-000029-index.htm
2020-02-22Christopher BowdenChief Medical OfficerBuy3,333.006,914.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000023/0001439222-20-000023-index.htm
2019-01-20Christopher BowdenChief Medical OfficerBuy6,265.007,189.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004950/0001209191-19-004950-index.htm
2019-03-15Christopher BowdenChief Medical OfficerSell1,300.0064.6484,032.007,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell100.0068.726,872.007,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2018-09-05David P SchenkeinChief Executive OfficerBuy72,619.002.34169,928.4672,619.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell1,500.0068.09102,135.007,338.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2018-09-05David P SchenkeinChief Executive OfficerBuy2,500.0031.6479,100.0075,119.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2019-02-16Carman AlensonPrincipal Accounting OfficerBuy790.00790.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2019-02-16Christopher BowdenChief Medical OfficerBuy2,750.008,013.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011489/0001209191-19-011489-index.htm
2020-05-20Christopher BowdenChief Medical OfficerSell3,583.0050.01179,200.168,306.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2018-09-10David P SchenkeinChief Executive OfficerBuy8,730.0031.64276,217.2083,849.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050631/0001209191-18-050631-index.htm
2020-04-13Jonathan BillerChief Legal OfficerBuy8,523.008,523.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000032/0001439222-20-000032-index.htm
2019-03-15Christopher BowdenChief Medical OfficerSell8,700.0064.09557,583.008,538.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2020-02-22Carman AlensonPrincipal Accounting OfficerBuy691.00875.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000021/0001439222-20-000021-index.htm
2020-02-13Christopher BowdenChief Medical OfficerBuy7,100.0035.16249,636.008,750.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell2,546.0066.85170,200.108,838.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2019-02-16David P SchenkeinDirectorBuy8,125.0091,974.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011498/0001209191-19-011498-index.htm
2020-02-16Carman AlensonPrincipal Accounting OfficerBuy790.00974.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2019-11-13David P SchenkeinDirectorBuy8,064.0031.00249,984.0097,567.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000023/0001439222-19-000023-index.htm